IndraLab

Statements


EGF sumoylates OTUB2. 11 / 11
| 6 5

reach
"Poly-SUMOylated OTUB2, which was induced by Epidermal growth factor (EGF) and oncogenic KRAS, was shown to bind and activate YAP/TAZ promoting tumor metastasis [68]."

sparser
"Interestingly, the SUMOylation of OTUB2 is induced by EGF and KRAS [ xref ]."

reach
"Therefore, our observations suggest that EGF and RAS activation might be able to regulate YAP/TAZ through SUMOylating OTUB2."

reach
"Interestingly, the SUMOylation of OTUB2 is induced by EGF and KRAS [78]."

sparser
"Furthermore, OTUB2 sumoylation is stimulated by EGF and oncogenic KRAS, which is essential for EGF and KRAS to stabilize Yap/Taz ( xref )."

reach
"Thus, these clinical data support our model that EGF signaling or RAS activation stimulates OTUB2 SUMOylation and thereby stabilizes YAP/TAZ, which enhances cancer stemness and metastasis ( Figure 7 K[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Moreover, we found that EGF, which can activate RAS, also promotes OTUB2 SUMOylation."

sparser
"Moreover, OTUB2 poly-SUMOylation was stimulated by epidermal growth factor (EGF) and oncogenic KRAS mutation."

sparser
"Importantly, EGF and oncogenic KRAS induce OTUB2 poly-SUMOylation and thereby activate YAP/TAZ."

sparser
"SUMOylation of OTUB2 by EGF and KRAS stabilizes YAP in the cytosol through deubiquitination, further regulating YAP activation."

reach
"Moreover, OTUB2 poly-SUMOylation was stimulated by epidermal growth factor (EGF) and oncogenic KRAS mutation."